Detection of the endogenous mu opioid receptor (mopr) in brain

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Commercial antibodies for endogenous seven-transmembrane receptors (7TMRs) often lack utility for immunoblotting.
• Accurate identification of 7TMRs is critical for understanding cellular signaling and developing therapeutics.
• The mu opioid receptor (MOPR) serves as a key example for challenges in 7TMR detection.

Purpose of the Study:

• To highlight the difficulties in validating antibodies for endogenous 7TMR immunoblotting.
• To demonstrate the importance of employing multiple independent methods for reliable receptor identification.
• To underscore the necessity of using knock-out models for confirming target specificity.

Main Methods:

• Utilized knock-out (K/O) mice to establish target specificity.
• Employed multiple independent approaches: ligand affinity-labeling, receptor phosphorylation studies, and immunoblotting.
• Analyzed receptor identification following sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).

Main Results:

• Convergence of pharmacological and biochemical data provided unequivocal identification of the mu opioid receptor (MOPR).
• Observed variations in relative molecular masses and band patterns were attributed to differential N-glycosylation.
• Glycosylation extent varied across different cell lines, brain regions, and species.

Conclusions:

• Rigorous validation using knock-out models and multiple biochemical techniques is essential for identifying 7TMRs.
• The mu opioid receptor (MOPR) identification serves as a robust example of successful, validated detection.
• Understanding glycosylation patterns is key to interpreting molecular weight variations in 7TMR analysis.